Publications by authors named "Idalia Parra-Avila"
Background: Solid Organ Transplant recipients (SOTR) appear to be at particular high risk for critical COVID-19 due to immunosuppressive drugs and comorbidities. We report the first description of clinical course and short-term outcomes of kidney and liver transplant recipients with confirmed COVID-19 in Mexico. The objective of this paper was evaluate the clinical course of transplant patients with COVID-19 infection.
View Article and Find Full Text PDFBackground: Female renal transplant recipients (RTR) are at high risk of human papillomavirus (HPV)-related anogenital premalignancies and cancer. The aim of this study was to estimate the incidence of cervical intraepithelial lesions (IL) and HPV infection, and their associated factors, in Mexican RTR.
Methods: This is a prospective cohort study conducted between January 2011 and December 2017.
Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial.
Nephrol Dial Transplant
November 2020
Background: Symptomatic urinary tract infection (UTI) is the most common infectious complication in renal transplant recipients (RTRs). Fosfomycin (FOS) is an attractive alternative for prophylaxis because it does not interact with immunosuppressants; although 90% is excreted unchanged in the urine, it does not require adjustment for renal function for single dose prophylaxis.
Methods: RTRs were recruited into this randomized, double-blind, placebo-controlled trial.
Article Synopsis
- There is currently no specific antiviral treatment for parvovirus B19 (PVB19) infection, prompting this study to evaluate treatment outcomes in kidney transplant recipients (KTR).
- The research involved a retrospective review over 16 years, analyzing eight cases at the institution and 120 cases from other medical literature, revealing that severe anemia was common among KTR affected by PVB19.
- The findings suggest that reducing immunosuppression and administering low-dose intravenous immunoglobulin (IVIG) can effectively manage PVB19 in KTR, with similar outcomes to standard treatments and no recurrences noted in the follow-up period.
Objective: The number of successful pregnancies in kidney transplant (KT) recipients has increased in recent years. Little evidence is available about the risk of in utero immunosuppressive exposure for long-term cognitive consequences. The aim of this study was to evaluate the impact of immunosuppression during pregnancy on intellectual performance of children born to KT recipients.
View Article and Find Full Text PDF